![Sounds of Science artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/de/13/d3/de13d380-9937-229e-fc2c-bb76e6e04d1e/mza_7252023560061756625.jpg/100x100bb.jpg)
Ep. 70: Benjamin Oakes and the Promise of CRISPR
Sounds of Science
English - March 05, 2024 11:48 - 28 minutes - 39.7 MB - ★★★★★ - 13 ratingsLife Sciences Science Technology biotech drugdiscovery pharmaceutical research science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Ep. 69: Past and Future of Endotoxin Testing
This month I am joined by Benjamin Oakes, scientist, entrepreneur, and co-founder of Scribe Therapeutics. He studied at UC Berkeley, working in the Doudna Lab and Savage Lab during the earliest days of CRISPR. We discuss his personal vision for the future of CRISPR, encouraging advances in the field, and the first ever drug approval for a CRISPR based therapy.